Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Microbial nucleotides is a broad, non-specific term encompassing the building blocks of genetic material (DNA and RNA) and signaling molecules (such as cyclic dinucleotides) found in bacteria, viruses, fungi, and parasites. While these molecules are essential for microbial life and can act as Pathogen-Associated Molecular Patterns (PAMPs) that trigger the host innate immune system via receptors like TLR9 or STING, the term itself does not describe a single therapeutic target. In drug discovery, specific enzymes involved in the synthesis, salvage, or polymerization of these nucleotides—such as DNA polymerases, reverse transcriptases, or dihydrofolate reductase—are the actual targets for antimicrobial and antiviral therapies. Consequently, 'Microbial nucleotides' is considered an incorrect or overly broad designation for a therapeutic target, as it refers to a chemical class rather than a specific functional protein or receptor (Source: Nature Reviews Microbiology, 2019; Frontiers in Immunology, 2020).
Not applicable as this is a broad class of molecules rather than a specific protein target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Microbial nucleotides.